Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial

Author:

Sanchez LeilaniORCID,Nakama Takahiro,Nagai Hideaki,Matsuoka Osamu,Inoue Satoshi,Inoue Takahiro,Shrestha Anju,Pandey Aseem,Chang Lee-JahORCID,De Bruijn Iris

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference22 articles.

1. Japanese Surveillance Systems and Treatment for Influenza;Zaraket;Curr Treat Options Infect Dis,2016

2. Influenza virus-related critical illness: prevention, diagnosis, treatment;Chow;Crit Care,2019

3. High-risk Groups for Influenza Complications;Uyeki;JAMA,2020

4. Introductory paper: High-dose influenza vaccine;Diaco;Vaccine,2021

5. Basic Complete Tabulation on Population and Households of the 2020 Population Census of Japan was released. Statistics Bureau, Ministry of Internal Affairs and Communications, Japan. https://www.stat.go.jp/english/info/news/20211228.html. Accessed on 12th October 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3